On July 20, 2009, Shareholders of Wyeth (“WYE”) voted concerning the proposed merger with Pfizer Inc. (“PFE”). The merger was approved and subsequently consummated on October 15, 2009. As a result, each existing WYE Common Share will be converted into the right to receive .985 PFE Common Shares and $33.00 Cash. Cash will be paid in lieu of fractional PFE shares.
This action will be coordinated with the Options Clearing Corporation.
CME Group is the world's leading and most diverse derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.